Learn more

RANA THERAPEUTICS INC

Overview
  • Total Patents
    124
  • GoodIP Patent Rank
    25,607
  • Filing trend
    ⇩ 75.0%
About

RANA THERAPEUTICS INC has a total of 124 patent applications. It decreased the IP activity by 75.0%. Its first patent ever was published in 2012. It filed its patents most often in WIPO (World Intellectual Property Organization), United States and Canada. Its main competitors in its focus markets pharmaceuticals, biotechnology and organic fine chemistry are IONIS PHARMACEUTICALS INC, BIOMARIN TECH BV and REGENERTECH PTY LTD.

Patent filings per year

Chart showing RANA THERAPEUTICS INCs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Krieg Arthur M 68
#2 Subramanian Romesh 66
#3 Mcswiggen James 65
#4 Lee Jeannie T 59
#5 Ozsolak Fatih 32
#6 Barsoum James 9
#7 Uhlmann Eugen 8
#8 Woo Caroline 8
#9 Severgnini Mariano 6
#10 Romesh Subramanian 5

Latest patents

Publication Filing date Title
WO2017075030A1 Methods and compositions for increasing smn expression
WO2015023938A1 Epigenetic regulators of frataxin
US2016201064A1 Compositions and methods for modulating expression of frataxin
CA2921459A1 Oligonucleotides targeting euchromatin regions of genes
CA2921457A1 Heterochromatin forming non-coding rnas
KR20160027968A Compositions and methods for modulating foxp3 expression
WO2013173637A1 Compositions and methods for modulating gene expression
AU2013262656A1 Compositions and methods for modulating UTRN expression
WO2013173652A1 Compositions and methods for modulating gene expression
US2015232836A1 Compositions and methods for modulating gene expression
CA2873772A1 Compositions and methods for modulating bdnf expression
CN104540947A Compositions and methods for modulating SMN gene family expression
AU2013262709A1 Compositions and methods for modulating MECP2 expression
CA2873801A1 Compositions and methods for modulating apoa1 and abca1 expression
US2015159161A1 Compositions and methods for modulating pten expression